MLA Annual Research Grant
The Manitoba Lung Association’s Annual Research Grant supports Manitoba-based researchers whose work advances lung health and helps all Manitobans breathe with ease.
View the MLA Research Grant recipients and current funding opportunities
Research Manitoba Trainee Awards
Each year, the Manitoba Lung Association partners with Research Manitoba to support emerging researchers dedicated to advancing lung health. Through the Research Manitoba Trainee Awards, we proudly select and fund outstanding students with Master Studentship Awards.
View Research Manitoba Studentship Recipients Supported by MLA
Elenore Haywood Lung Association Manitoba Convocation Prize
Awarded at the University of Manitoba’s Convocation and Awards Luncheon for Occupational Therapy, Physical Therapy, Respiratory Therapy, and MSc Rehabilitation Sciences, for achieving the highest GPA in Clinical Assessment in Respiratory Care. This award is made possible through the generosity of our donors, and we extend our heartfelt thanks for their support of excellence in respiratory care education.
View Elenore Haywood Lung Association Manitoba Convocation Prize Recipients
UM AirSAFE Lab Partnership
We are proud to be a partner of the new $4.8million UM AirSAFE lab. This pioneering centre, led by Dr. Andrew Halayko and Dr. Neeloffer Mookherjee, is the first in Canada to bring together experts from multiple disciplines to study the impact of air pollution on health. With more than 20% of premature deaths linked to air pollution, the AirSAFE lab's research will be crucial in developing policies to improve air quality and public health. We are excited to be part of this vital initiative.
Learn More about the AirSafe Lab Project
2023 Manitoba Lung Association and Canadian Lung Association PhD Studentship: Saeid Maghsoudi
Project Title: Inhibition of Adenylyl Cyclase Isoform 6 by Cysteine Nitrosylation in Hypoxic Pulmonary Hypertension, and Rescue with Novel Forskolin Derivatives
This PhD project is dedicated to developing new treatments for "blue babies," newborns who struggle with severe oxygen deprivation due to persistent pulmonary hypertension (PPHN). This life-threatening condition affects over 800 infants worldwide each day. Current treatments can be insufficient or lead to serious side effects, so this research is focused on creating safer, more effective options.
A key target is an enzyme in the lungs called Adenylyl Cyclase 6 (AC6), essential for oxygen delivery but impaired in low-oxygen conditions like PPHN. By developing a drug that reactivates AC6, the project aims to improve oxygen flow for these infants. These findings could also benefit adults with respiratory issues, such as pulmonary hypertension, cystic fibrosis, and asthma.
Maghsoudi & Dakshinamurti Lab Team
Donate Today
There are gifted, passionate and determined researchers here in Manitoba.
Your donations fund important lung health research and at the same time, you are helping build a research community right here in Manitoba.
